Aequus Pharmaceuticals (AQS.V), a specialty pharma company with a business model of acquiring and re-platforming existing approved biotech and health products to appeal to a wider market, has announced…
Moneyball Picks
Just a few months since announcing they were merging with Askott Entertainment, a deal that brought casino gaming and daily fantasy sports access to FansUnite’s (FANS.C) sports betting platform,…
Let’s take a step back. Take a breath. Maybe meditate or toss back a tequila shot. Okay, we good for a chat? It’s been a rough few years for…
When we first talked about Tocvan Ventures (TOC.C) back in June, it was selling for around $0.15 and nobody was really talking about it. In certain markets, hype is…
If you’ve been paying attention over the last few years, you’ve seen a few nice runs for companies engaged in the security/military space. Patriot One (PAT.C) has done nicely…
For the last several years, a lot of stories I’ve written on this site have been about promise. The promise of something better, cheaper, with more upside, with less…
After a months long quiet period in which investors had to wait patiently for AMPD Ventures (AMPD.C) pipeline contracts to land, a period that also saw the stock slide…
E-sports stocks are, by and large, a silly thing right now, with a lot of folks bringing out deals that make little sense financially. As with the psychedelic space,…
If you’ve been in the public markets on the microcap side for any length of time, the bodies stack up on your portfolio after a while. You know the…
I know you guys are all hopped up on goofballs buying gold right now, and shrooms before that, and biotech if you’re clever, and oil and gas for a…